Lg Healthcare Breakthrough Etf Net Asset
| DOCT Etf | CHF 11.60 0.38 3.17% |
As of the 5th of February, LG Healthcare owns the Market Risk Adjusted Performance of 0.8597, mean deviation of 0.8186, and Standard Deviation of 1.18. LG Healthcare Breakthrough technical analysis lets you operate past data patterns with an objective to determine a pattern that forecasts the direction of the etf's future prices. Please verify LG Healthcare Breakt semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation to decide if LG Healthcare Breakthrough is priced some-what accurately, providing market reflects its prevailing price of 11.6 per share.
LG Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LG Healthcare's valuation are provided below:LG Healthcare Breakthrough does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. DOCT |
LG Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LG Healthcare's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LG Healthcare.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in LG Healthcare on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding LG Healthcare Breakthrough or generate 0.0% return on investment in LG Healthcare over 90 days. LG Healthcare is related to or competes with Vanguard FTSE, and UBS ETF. The investment objective of the LG Healthcare Breakthrough UCITS ETF is to provide exposure to the global healthcare tec... More
LG Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LG Healthcare's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LG Healthcare Breakthrough upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.3 | |||
| Information Ratio | 0.0512 | |||
| Maximum Drawdown | 6.23 | |||
| Value At Risk | (1.73) | |||
| Potential Upside | 2.43 |
LG Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LG Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LG Healthcare's standard deviation. In reality, there are many statistical measures that can use LG Healthcare historical prices to predict the future LG Healthcare's volatility.| Risk Adjusted Performance | 0.0709 | |||
| Jensen Alpha | 0.0914 | |||
| Total Risk Alpha | 0.0405 | |||
| Sortino Ratio | 0.0464 | |||
| Treynor Ratio | 0.8497 |
LG Healthcare February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0709 | |||
| Market Risk Adjusted Performance | 0.8597 | |||
| Mean Deviation | 0.8186 | |||
| Semi Deviation | 0.9045 | |||
| Downside Deviation | 1.3 | |||
| Coefficient Of Variation | 1116.81 | |||
| Standard Deviation | 1.18 | |||
| Variance | 1.38 | |||
| Information Ratio | 0.0512 | |||
| Jensen Alpha | 0.0914 | |||
| Total Risk Alpha | 0.0405 | |||
| Sortino Ratio | 0.0464 | |||
| Treynor Ratio | 0.8497 | |||
| Maximum Drawdown | 6.23 | |||
| Value At Risk | (1.73) | |||
| Potential Upside | 2.43 | |||
| Downside Variance | 1.68 | |||
| Semi Variance | 0.8181 | |||
| Expected Short fall | (1.14) | |||
| Skewness | 0.1504 | |||
| Kurtosis | 1.5 |
LG Healthcare Breakt Backtested Returns
At this stage we consider DOCT Etf to be very steady. LG Healthcare Breakt retains Efficiency (Sharpe Ratio) of 0.0845, which conveys that the entity had a 0.0845 % return per unit of price deviation over the last 3 months. We have found twenty-six technical indicators for LG Healthcare, which you can use to evaluate the volatility of the etf. Please verify LG Healthcare's Market Risk Adjusted Performance of 0.8597, standard deviation of 1.18, and Mean Deviation of 0.8186 to check out if the risk estimate we provide is consistent with the expected return of 0.1%. The etf owns a Beta (Systematic Risk) of 0.11, which conveys not very significant fluctuations relative to the market. As returns on the market increase, LG Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding LG Healthcare is expected to be smaller as well.
Auto-correlation | 0.03 |
Virtually no predictability
LG Healthcare Breakthrough has virtually no predictability. Overlapping area represents the amount of predictability between LG Healthcare time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LG Healthcare Breakt price movement. The serial correlation of 0.03 indicates that only 3.0% of current LG Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, LG Healthcare Breakthrough has a Net Asset of 166.48 M. This is much higher than that of the LGIM Managers (Europe) Limited family and significantly higher than that of the Sector Equity Healthcare category. The net asset for all Switzerland etfs is notably lower than that of the firm.
DOCT Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LG Healthcare's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of LG Healthcare could also be used in its relative valuation, which is a method of valuing LG Healthcare by comparing valuation metrics of similar companies.LG Healthcare is rated # 3 ETF in net asset as compared to similar ETFs.
DOCT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LG Healthcare's current stock value. Our valuation model uses many indicators to compare LG Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LG Healthcare competition to find correlations between indicators driving LG Healthcare's intrinsic value. More Info.LG Healthcare Breakthrough is rated below average in one year return as compared to similar ETFs. It also is rated below average in three year return as compared to similar ETFs reporting about 0.35 of Three Year Return per One Year Return. The ratio of One Year Return to Three Year Return for LG Healthcare Breakthrough is roughly 2.85 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LG Healthcare's earnings, one of the primary drivers of an investment's value.Fund Asset Allocation for LG Healthcare
The fund invests 99.85% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides LG Healthcare's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors for a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will manage securities in the fund's portfolio as market conditions and the fund's objectives change.
DOCT Fundamentals
| Total Asset | 166.48 M | |||
| One Year Return | 17.40 % | |||
| Three Year Return | 6.10 % | |||
| Five Year Return | (4.60) % | |||
| Net Asset | 166.48 M | |||
| Equity Positions Weight | 99.85 % |
About LG Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LG Healthcare Breakthrough's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LG Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LG Healthcare Breakthrough based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DOCT Etf
LG Healthcare financial ratios help investors to determine whether DOCT Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCT with respect to the benefits of owning LG Healthcare security.